55 th. Catanzaro. Annual Meeting of the Italian Cancer Society September : understanding onc-omics for patient-tailored cancer therapy

Size: px
Start display at page:

Download "55 th. Catanzaro. Annual Meeting of the Italian Cancer Society. 23 26 September 2013. : understanding onc-omics for patient-tailored cancer therapy"

Transcription

1 In collaboration with

2 CONGRESS VENUE Università degli Studi Magna Græcia di Viale Europa Germaneto - Villaggio Guglielmo Congress Center Piazza Susanna, Copanello - ORGANIZING SECRETARIAT Adria Congrex Srl Via Sassonia, Rimini RN Ph Fax Web site SIC SECRETARIAT Società Italiana di Cancerologia Via G. Venezian, Milan Ph Fax Web site

3 Welcome Address Dear Members of SIC, Colleagues and Friends, It is our great pleasure to welcome you in for the 55th (SIC). The title of the 2013 meeting is Welcome to the South - Understanding Onc OMICS for Patient Tailored Cancer Therapy. This title echoes a popular series of movies and underlines the fact that this conference is the first SIC Meeting to be held in Calabria. In addition to its wealth of natural beauty and of history, this Region hosts one of the youngest and most dynamic Universities in Italy, the University Magna Græcia of, strongly commitment to bio-medical research and in particular to translational cancer research. The recently-established University Campus S. Venuta, where the inaugural session will be held, is a modern, residential campus equipped with state-of-art facilities for cell biology, functional genomics and proteomics, bio-computing and drug design, and for pre-clinical studies in animal models of disease. The 2013 Meeting will be focused on highly relevant and timely topics including Non-coding RNAs, Cancer Biochemistry and Metabolism, Cancer Genomics and Epigenomics, Cancer Stem Cells, Animal Modelling of Cancer, Advanced Diagnostics and Therapeutics. The basic goal of this meeting is to highlight how world-wide efforts to catalogue mutations in multiple cancer types are underway and discuss whether and how this may lead to novel discoveries that will be translated into new diagnostic tools, prognostic indicators and therapeutic targets. There will be plenary lectures and presentations from top Italian and international experts in the field of cancer, together with those given by young scientists, and focused breakthrough sessions particularly dedicated to a comprehensive update on the most recent laboratory and clinical developments in the field of cancer. Traditional SIC events will be the Giorgio Prodi memorial lecture, and the joint session with the Italian Association of Medical Oncology (AIOM), to highlight the connection between basic research and new therapeutic approaches. The opening lecture will be held by Daniel Peeper, and the closing lecture by John Quackenbush. Our Society continues to encourage the young investigators with initiatives aimed at improving their professional growth and qualification. In this respect, the Meeting will dedicate to young scientists four poster discussion sessions focusing on highly relevant topics, the Piero Trivella and EACR Prizes for the best posters, the Elena Cappannini Award for the best publication, the Pezcoller Foundation scholarship, as well as travel grants and formative credits. We thank you for your participation, and hope that this Meeting will be most enjoyable and productive for everybody. Giuseppe Viglietto Scientific Coordinator Riccardo Dolcetti SIC President 1

4 WITH THE AUSPICES OF University of Magna Graecia Centro interdipartimentale di genomica e patologia molecolare Fondazione per la Ricerca e la Cura dei Tumori Tommaso Campanella 2

5 Committee SIC SCIENTIFIC BOARD President Riccardo Dolcetti (CRO-IRCCS, National Cancer Institute, Aviano, Pordenone, Italy) President Elect Silvia Giordano (Institute for Cancer Research and Treatment, University of Turin, Candiolo, Italy) Board Anna Bagnato (Regina Elena National Cancer Institute, Rome, Italy) Vincenzo Bronte (University of Verona, Italy) Maurizio D Incalci ( Mario Negri Institute for Pharmacological Research, Milan, Italy) Nicola Normanno (National Cancer Institute G. Pascale, Naples, Italy) Salvatore Pece (IFOM-IEO Campus, University of Milan, Italy) Katia Scotlandi (IRCCS Orthopaedic Rizzoli Institute, Bologna, Italy) Gabriella Sozzi (IRCCS National Cancer Institute, Milan, Italy) Stefania Tommasi (National Cancer Centre Giovanni Paolo II, Bari, Italy) Giuseppe Viglietto (University Magna Græcia,, Italy) Past President Alfredo Fusco ( Federico II University, Naples, Italy) Representative for Young Researchers Chiara Gabellini (Regina Elena National Cancer Institute, Rome, Italy) Pierlorenzo Pallante (Institute of Endocrinology and Experimental Oncology, CNR, Naples, Italy) SCIENTIFIC AND ORGANIZING COMMITTEE Scientific Coordinator Giuseppe Viglietto (University Magna Græcia,, Italy) Local Scientific Committee Gennaro Ciliberto (National Cancer Institute G. Pascale, Naples, Italy; University Magna Græcia,, Italy) Francesco Saverio Costanzo (University Magna Graecia,, Italy) Gianni Cuda (University Magna Græcia,, Italy) Dolores Di Vizio (Cedars Sinai Medical Center, Los Angeles, CA, USA) Marcello Maggiolini (University of Cosenza, Italy) Giovanni Morrone (University Magna Græcia,, Italy) Pierosandro Tagliaferri (University Magna Græcia,, Italy) Pierfrancesco Tassone (University Magna Græcia,, Italy) 3

6 Faculty Valter Agosti University Magna Græcia,, Italy Paolo Ascierto National Cancer Institute G. Pascale, Naples, Italy Anna Bagnato Regina Elena National Cancer Institute, Rome, Italy Rosa Bernardi IRCCS San Raffaele Hospital, Milan, Italy Renzo Canetta Bristol-Myers Squibb, Wallingford, CT, USA Ugo Cavallaro European Institute of Oncology, Milan, Italy Paola Chiarugi University of Florence, Italy Gennaro Ciliberto National Cancer Institute G. Pascale, Naples, Italy; University Magna Græcia,, Italy Pierpaolo Correale University of Siena, Italy Giovanni Cuda University Magna Græcia,, Italy Donatella Del Bufalo Regina Elena National Cancer Institute, Rome, Italy Francesca Demichelis University of Trento, Italy Simona De Summa National Cancer Centre Giovanni Paolo II, Bari, Italy Maurizio D Incalci Mario Negri Institute for Pharmacological Research, Milan, Italy Federica Di Nicolantonio Institute for Cancer Research and Treatment, Candiolo, Turin, Italy Dolores Di Vizio Cedars Sinai Medical Center, Los Angeles, CA, USA Riccardo Dolcetti CRO-IRCCS, National Cancer Institute, Aviano, Pordenone, Italy Giulio Draetta MD Anderson Cancer Center, Houston, TX, USA Manuela Ferracin University of Ferrara, Italy Riccardo Fodde Josephine Nefkens Institute Erasmus University Medical Centre, Rotterdam, The Netherlands Niels Frandsen Exiqon, Vedbaek, Denmark Guido Franzoso Imperial College, London, United Kingdom Alfredo Fusco Federico II University, Naples, Italy Cecilia Garofalo IRCCS Rizzoli Orthopaedic Institute, Bologna, Italy Silvia Giordano Institute for Cancer Research and Treatment, University of Turin, Candiolo, Italy Eric Holland Memorial Sloan Kettering Cancer Center, New York, NY, USA Antonio Iavarone Columbia University, New York, NY, USA Jeffrey J. Legos GlaxoSmithKline, Collegeville, PA, USA Marco Macagno University of Turin, Italy Norman J. Maitland University of York, United Kingdom Maria Caterina Mione Karlsruhe Institute of Technology, Eggenstein-Leopoldshafen, Germany Andrea Morandi University of Florence, Italy Giovanni Morrone University Magna Græcia,, Italy Nicola Normanno National Cancer Institute G. Pascale, Naples, Italy Giorgio Parmiani IRCCS San Raffaele Hospital, Milan, Italy Daniel Peeper The Netherlands Cancer Institute, Amsterdam, The Netherlands John Quackenbush Dana-Farber Cancer Institute, Boston, MA, USA Lucia Ricci Vitiani ISS, Istituto Superiore di Sanità, Rome, Italy Mercedes Robledo Spanish National Cancer Centre (CNIO), Madrid, Spain Mark A. Rubin Weill Cornel Medical College, New York, NY, USA Massimo Santoro Federico II University, Naples, Italy Aldo Scarpa University of Verona, Italy Jan J. Schuringa Faculty of Medical Sciences, Hematology, Groningen, The Netherlands Katia Scotlandi IRCCS Rizzoli Orthopaedic Institute, Bologna, Italy Salvatore Siena Niguarda Ca Granda Hospital, Milan, Italy Frank J. Slack Yale University, New Haven, CT, USA Gabriella Sozzi IRCCS National Cancer Institute, Milan, Italy Henk J. Stunnenberg Nijmegen Centre for Molecular Life Sciences, Nijmegen, The Netherlands Pierosandro Tagliaferri University Magna Græcia,, Italy Pierfrancesco Tassone University Magna Græcia,, Italy Stefania Tommasi National Cancer Centre Giovanni Paolo II, Bari, Italy Giancarlo Vecchio Federico II University, Naples, Italy Giuseppe Viglietto University Magna Græcia,, Italy Stefano Volinia University of Ferrara, Italy 4

7 Programme at a glance Monday, September 23th - University of 1300 Registration Opening ceremony Opening lecture NON CODING RNAS CANCER BIOCHEMISTRY AND METABOLISM Welcome cocktail Tuesday, September 24th - Villaggio Guglielmo 0730 Registration Meet the expert informal round CANCER GENOMICS AND EPIGENOMICS Coffee break ADVANCED OMIC TECHNOLOGIES IN CANCER RESEARCH Lunch Poster viewing with the presence of Authors ADVANCED DIAGNOSTICS AND THERAPEUTICS Coffee break Meeting of the SIC young investigators Wednesday, September 25th - Villaggio Guglielmo Meet the expert informal round Poster Discussion 1A - 1B Coffee break Giorgio Prodi lecture Poster viewing with the presence of Authors Lunch Poster Discussion 2A - 2B CANCER STEM CELLS AWARD CEREMONY SIC General Assembly Social Dinner Thursday, September 26th - Villaggio Guglielmo ANIMAL MODELS OF CANCER Coffee break Closing lecture Award for the best oral selected presentation Closing remarks Lunch 5

8 13.00 Registration OPENING CEREMONY Monday 23 September SCIENTIFIC PROGRAMME Ve n u e Un i v e r s i t y o f Ca t a n z a r o, Au d i t o r i u m GREETINGS FROM THE AUTHORITIES A. Quattrone (Magnifico Rettore Magna Graecia University,, Italy) R. Dolcetti (SIC President, Aviano PN, Italy) GREETINGS FROM EACR D. Del Bufalo (EACR Executive Committee Member, Regina Elena National Cancer Institute, Rome, Italy) OPENING LECTURE Chair R. Dolcetti (Aviano PN, Italy) Function-based screening for therapeutic targets in cancer D. Peeper (Amsterdam, The Netherlands) Sponsored by EACR NON CODING RNAS Chairmen S. Giordano (Turin, Italy) - P. Tassone (, Italy) MicroRNAs as targeted therapeutics and therapeutic targets in cancer F.J. Slack (New Haven, USA) MicroRNA and lung cancer G. Sozzi (Milan, Italy) Role of MicroRNAs in progression and invasiveness of breast cancer S. Volinia (Ferrara, Italy) The role of mirnas in regulating angiogenesis C25 in BRCA related breast cancer K. Danza (IRCCS-National Cancer Center Giovanni Paolo II,Bari, Italy), S. De Summa, B. Pilato, R. Lacalamita, O. Popescu, R. Lambo, M. Carella, S. Tommasi mirna landscape in Stage I Epithelial Ovarian Cancer C29 defines the histotype specificities L. Paracchini (Mario Negri Institute for Pharmacological Research, Milan, Italy), E. Calura, L. Zanotti, R. Fruscio, M. Di Marino, L. Beltrame., R. Baldo R., S. Magni, A. Ravaggi, E. Bignotti, G. Tognon, E. Sartori, S. Pecorelli, D. Katsaros, M. D Incalci, C. Romualdi, S. Marchini 6

9 Monday 23 September SCIENTIFIC PROGRAMME Ve n u e Un i v e r s i t y o f Ca t a n z a r o, Au d i t o r i u m CANCER BIOCHEMISTRY AND METABOLISM Chairmen G. Cuda (, Italy) - G. Vecchio (Naples, Italy) Cancer-selected targeting of the NF-ĸB pathway G. Franzoso (London, UK) Reciprocal metabolic deregulation of tumors and their stroma P. Chiarugi (Florence, Italy) Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune F2 C-terminal interaction M. Carotenuto, P. De Antonellis, L. Liguori, D. Spano, A. M. Bello, V. Ferrucci, A. Alonzi, D. Magliulo, C. M. Chiarolla, S. Di Somma, N. Aiese, M. Zollo (CEINGE, Naples, Italy) The mitochondrial chaperone TRAP1 promotes neoplastic growth by inhibiting G7 succinate dehydrogenase A. Rasola (University of Padua, Italy) Welcome Cocktail Shuttle Bus from the University to Villaggio Gugliemo 7

10 7.30 Registration Tuesday 24 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o MEET THE EXPERT INFORMAL ROUND Parallel Sessions An i ma l Mo d e l s E. Holland (New York, USA) - M. Mione (Eggenstein-Leopoldshafen, Germany) Ca n c e r Stem Cells N. Maitland (York, United Kingdom) - R. Fodde (Rotterdam, The Netherlands) CANCER GENOMICS AND EPIGENOMICS Chairmen K. Scotlandi (Bologna, Italy) - S. Tommasi (Bari, Italy) The drivers of oncogenesis and master regulators of glioblastoma A. Iavarone (New York, USA) Next generation histopathological diagnosis from genomics to clinical application A. Scarpa (Verona, Italy) From OMIC to the patient M. Robledo (Madrid, Spain) Coffee Break Molecular archeology from next generation explorations F. Demichelis (Trento, Italy) Detection of genetic and epigenetic alterations in plasma circulating tumor DNA F. Di Nicolantonio (Turin, Italy) A massive parallel sequencing approach in a selected hereditary C19 breast/ovarian cancer serie highlights ATM as an important breast cancer predisposing A. Buffone, A. Coppa (Sapienza University of Rome, Italy), S. Casadei, A. Prodosmo, V. Colicchia, A. Nicolussi, S. D Inzeo, S. Brizi, S. Soddu, G. Giannini Estrogen receptor BETA/AGO2 complex binds to breast cancer cell genome H20 and mediates transcriptional gene regulation by the nuclear receptor R. Tarallo (University of Salerno, Baronissi,Italy), G. Nassa, G. Giurato, G. Bruno, A. Salvati, L. Ricciardi T. Rocco, F. Rizzo, A. Weisz 8

11 Tuesday 24 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o ADVANCED OMIC TECHNOLOGIES IN CANCER RESEARCH Chairmen G. Viglietto (, Italy) - G. Cuda (, Italy) Lunch How to implement therapeutic drug monitoring through mass spectrometry in oncology B. Casetta (AbSciex) Somatic variant screening in solid tumors with ion torrent semiconductor sequencing R. Tanzi (Life Technologies) Illumina solutions for cancer analysis N. Cirenei (Product Marketing Manager Europa Illumina) Initiatives in translational cancer research in Calabria brief presentation of the PON- and POR-funded projects A. Lidonnici (Biomedpark HEMMAS) POSTER VIEWING WITH THE PRESENCE OF THE AUTHORS ADVANCED DIAGNOSTICS AND THERAPEUTICS THE PHARMA S VIEW Chairmen G. Ciliberto (Naples, Italy) - M. D Incalci (Milan, Italy) LNA antisense oligonucleotides promising drug development platform and antisense tools for the study of RNA function in animals N. Frandsen (Exiqon, Vedbaek, Denmark) Challenges of drug discovery and development in the era of precision medicine J.J. Legos (GSK, Collegeville, USA) Immuno-oncology as a new modality of cancer treatment research and development R. Canetta (BMS, Wallingford, USA) Coffee Break THE CLINICIANS VIEW Joint Meeting SIC-AIOM Chairmen N. Normanno (Naples, Italy) - P. Tagliaferri (, Italy) Targeted drugs for melanoma P. Ascierto (Naples, Italy) Targeted drugs for colon carcinoma S. Siena (Milan, Italy) Combined immuno and chemotherapy/targeted therapy strategies G. Parmiani (Milan, Italy) Sponsored by EACR Colon cancer chemoimmunotherapy from bench to bedside P. Correale (Siena, Italy) MEETING OF SIC YOUNG INVESTIGATORS 9

12 Wednesday 25 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o MEET THE EXPERT INFORMAL ROUND Parallel Sessions Cancer Genomics A. Iavarone (New York, USA) - M.A. Rubin (New York, USA) Non Coding RNAs F.J. Slack (New Haven, USA ) Oncometabolics P. Chiarugi (Florence, Italy) POSTER DISCUSSION 1 Parallel Sessions Poster Discussion 1A Sala Cassiodoro CANCER genetics, epigenetics and control of gene expression Chairmen S. De Summa (Bari, Italy) - G. Viglietto (, Italy) E5 Critical role of zinc finger protein 521 in the control of growth and tumourigenicity of human medulloblastoma cells R. Spina, G. Filocamo, E. Iaccino, S. Scicchitano (University of Magna Graecia,, Italy), M. Lupia, E. Chiarella, T. Mega,F. Bernaudo, D. Pelaggi, M. Mesuraca, S. Pazzaglia, S. Semenkow, E.E. Bar, M. Kool,S. Pfister, H.M. Bond, C.G. Eberhart, C. Steinkuhler, G. Morrone E17 CXCR4 inhibition impairs stemness features and blocks the metastatic dissemination induced by chemotherapy of migrating lung cancer initiating cells G. Bertolini (IRCCS National Cancer Institute, Milan, Italy), M. Moro, M. Tortoreto, D. Wong, L. Gatti, R. Caserini, U. Pastorino, L. Roz,G. Sozzi C20 ATM protein kinase promotes HER2-dependent tumorigenesis V. Stagni (IRCCS-Fondazione Santa Lucia, Rome, Italy), V. Oropallo, M. Antonelli, R. Falcioni, A. Di Benedetto, M. Mottolese, D. Barila C23 SEMA6A and MICAL-1 sustain cell growth and survival of BRAF mutant human melanoma R. Loria, V. Perrotti, G. Bon, P. Baldassarri, I. Bersani, S. Rossi, R. Mortarini, A. Anichini, R. Falcioni (National Cancer Institute Regina Elena, Rome, Italy) H17 Histone deacetilase inhibitors repress the expression of the pro-invasive factor Runx2, in tumor cells, through a new intronic enhancer region V. Sancisi, G. Gandolfi, G. Damia, D. Ambrosetti, A. Ciarrocchi (Arcispedale S. Maria Nuova-IRCCS; Reggio Emilia, Italy) H4 MEF2 is a converging hub for HDAC4 and PI3K/Akt-induced transformation E. Di Giorgio (University of Udine, Italy), A. Clocchiatti, A. Sgorbissa, E. Gagliostro, C. Brancolini H3 Study of ADAR2 editing enzyme in astrocytoma proliferation A. Gallo (Ospedale Pediatrico Bambino Gesù IRCCS, Rome Italy), S. Tomaselli, F. Galeano, F. Locatelli E16 ERK5-inhibition as a novel approach to target CML stem cells E. Rovida (University of Florence, Italy), I. Tusa, G. Cheloni, N.S. Gray, X. Deng, P. Dello Sbarba 10

13 Wednesday 25 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o H21 Silencing of the collagen prolyl hydroxylases is associated with metastatic breast cancer and metastatic melanoma C. Lo Nigro (S. Croce General Hospital, Cuneo, Italy), H. Wang, L. Lattanzio, M. Monteverde, N. Syed, O. Garrone, M. Occelli, E. Hatzimichael, M. Merlano, C. Proby, A. Thompson, T. Crook Poster Discussion 1B Sala Ibico tumor immunology and microenvironment Chairmen A. Bagnato (Rome, Italy) - M. Macagno (Turin, Italy) U3 Effects induced by mir-29b on Multiple Myeloma (MM)-related immunological microenvironment C. Botta (University of Magna Graecia,, Italy), M. Rossi, M. R. Pitari, T. Del Giudice, A. Gullà, E. Morelli, L. Biamonte, N. Amodio, M. T. Di Martino, M. Ventura, P. Correale, P. Tagliaferri, P. Tassone U4 Exploiting immunogenic cancer cell death to improve dendritic cell-based immunotherapy J. Dal Col (CRO-IRCCS, Aviano PN; Italy), D. Martorelli, B. Montico, K. Mastorci, E. Comaro, R. Dolcetti B2 Role of senescent stroma in prostate cancer progression M. L. Taddei (University of Florence, Italy), G. Comito, L. Cavallini, E. Giannoni, P. Chiarugi F20 L-proline induces a mesenchymal like invasive program in embryonic stem cells by remodelling H3K9 and H3K36 methylation S. Comes, M. Gagliardi, N. Laprano, A. Fico, A. Cimmino, A. Palamidessi, C. Angelini, S. De Falco, G. Scita, E.J. Patriarca, M. R. Matarazzo, G. Minchiotti (Institute of Genetics and Biophysics A. Buzzati-Traverso, CNR, Naples, Italy) F6 F9 F3 CRM1-Selective Inhibitors of Nuclear Export (SINE) reduce the incidence of tumor spreading and improve overall survival in preclinical models of prostate cancer G. L. Gravina, M. Tortoreto, A. Mancini, P. Muzi, L. Ventura, A. Addis, Y. Landesman, D. McCauley, M. Kauffman, S. Shacham, N. Zaffaroni, C. Festuccia (University of L Aquila, Italy) Acidic microenvironment drives melanoma progression through cell to cell sustained exosome-mediated transfer of metastatic molecules Z. Boussadia (Istituto Superiore di Sanità, Rome, Italy), I. Parolini, F. Felicetti, C. Coscia, S. Camerini, C. Zanetti, A. De Feo, L. Pasquini, M. Biffoni, A. Carè, M. Sargiacomo Characterization of transgenic mouse model and derivative cells line of SCLC induced by HPV-16 E6/E7 R. Martinelli (University of Salerno, Baronissi, Italy), S.L. Nori, F. De Caro, G. Boccia, M. Capunzo 11

14 Wednesday 25 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o U11 Development of human bispecific antibodies against CD20/CD55 and CD20/59 for the treatment of B-cell disorders P. Macor (University of Trieste, Italy), E. Secco, N. Mezzaroba, S. Zorzet, P. Durigutto, T. Gaiotto, F. Ziller, L. De Maso, S. Biffi, S. Capolla, M. Calvaruso, C. Tripodo, C. Garrivo, V. Gattei, R. Marzari, F. Tedesco, D. Sblattero V8 Gelatinases promote progression and metastasis in leiomyosarcoma in vitro and in vivo C. Alias, A. D Angelo (Azienda Ospedaliero-Universitaria, Parma, Italy), L. Rocchi, S. Caraffi, R. Perris, D. Mangieri Coffee Break GIORGIO PRODI LECTURE Introduction R. Dolcetti (Aviano PN, Italy) From RET oncogene identification in thyroid cancer to targeted therapy M. Santoro (Naples, Italy) POSTER VIEWING WITH THE PRESENCE OF AUTHORS Lunch POSTER DISCUSSION 2 Parallel Sessions Poster Discussion 2A Sala Cassiodoro drug resistance, signal transduction, targeted therapy Chairmen V. Agosti (, Italy) C. Garofalo (Bologna, Italy) L4 L2 Activation of the MET receptor drives resistance to anti EGFR therapies in colorectal cancer M. Apicella (University of Turin, Italy), S. Corso, A. Bertotti, S. Hobor, E. Bonazzina, A. Sartore-Bianchi, S. Siena, L. Trusolino, A. Bardelli, S. Giordano Role of Hedgehog pathway in mediating resistance to anti EGFR TKIs in NSCLC F. M. Morgillo, C.D. Della Corte (Second University of Naples, Italy), F.P. Papaccio, D.V. Vitagliano, F.C. Ciardiello T12 Taxanes enhanced trastuzumab-mediated ADCC of tumor cells through NKG2D mediated NK cell recognition T. Triulzi (Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy), L. Sfondrini, S. Varchetta, V. Regondi, M. Di Modica, P. Casalini, A. Balsari, G. Bianchi, G. Mariani, E. Tagliabue T21 Src inhibitors act through different mechanisms to cooperate with EGFR or MEK inhibitors in NSCLC models sensitive or resistant to erlotinib R. Rosa (Federico II University of Naples), L. Formisano, C. D Amato, V. D Amato, L. Nappi, R. Marciano, L. Raimondo, C. Di Mauro, A. Petrone, A. Servetto, V. Damiano, S. De Placido, R. Bianco 12

15 Wednesday 25 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o T6 Histone deacetylase inhibition leads to enhanced sensitization to pemetrexed via induction of apoptosis and autophagy in non small cell lung tumor models M. Di Martile, (Regina Elena National Cancer Institute, Rome, Italy), D. Trisciuoglio, M. Desideri, C. Gabellini, T. De Luca, A. Eramo, R. De Maria, M. Milella, D. Del Bufalo T10 Anti-tumor activity of a mir-199 dependent oncolytic adenovirus E. Callegari (University of Ferrara, Italy), B. K. Elamin,.L. D Abundo, M. Negrini, S. Sabbioni T5 Activation of an early feedback survival loop involving phospho-erbb3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-erbb3 antibodies L. Fattore (Sapienza University of Rome, Italy), E. Marra, M. E. Pisanu, A. Noto, C. De Vitis, F. Belleudi, L. Aurisicchio, R. Mancini, M. R. Torrisi, P. A. Ascierto, G. Ciliberto L7 Molecular Mechanism of Resistance to Afatinib in EGFR Mutated Non-Small Cell Lung Cancer (NSCLC) cell lines and Potential Therapeutic Implications S. Coco (IRCCS, Azienda Ospedaliera Universitaria San Martino, Genoa, Italy), A. Truini, A. Alama, A. Garuti, E. Carminati, G. Barletta, M.G. Dal Bello, C. Genova, E. Rijavec, C. Sini, F. Grossi N16 Fenretinide (4-HPR) targets parental and cancer initiating medulloblastoma cells A. Pagani (University of Insubria Varese, Italy), D. Bartolini, A. Bruno, D.M. Noonan, A. Albini 13

16 Wednesday 25 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o Poster Discussion 2B Sala Ibico BIOMARKERS and therapy Chairmen D. Di Vizio (Los Angeles, USA) M. Ferracin (Ferrara, Italy) I3 I5 Functional connection between RAD51 and CCDC6 in homologous recombination directed repair in lung tumors new therapeutic perspectives? F. Morra (Institute of Endocrinology and Experimental Oncology, CNR, Naples, Italy), C. Luise, A. Marinelli, A. Milano, F. Merolla, A. Cerrato, A. Celetti PARP1 overexpression and mirna targeting DNA repair could they be biomarkers of the BRCAness phenotype? S. De Summa (National Cancer Centre Giovanni Paolo II, Bari, Italy), R. Pinto, B. Pilato, D. Petriella, K. Danza, E. Mattioli, D. Sambiasi, O. Palumbo, S. Tommasi P20 mir-205 and Trastuzumab potential as adjuvant therapeutic tool and predictive biomarker E. D Ippolito (Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy), I. Plantamura, M. Giussani, E. Liotti, L. Braccioli, P. Casalini, E. Tagliabue, M. V. Iorio S4 ImiR a reliable and accurate pipeline for analysis of small non coding RNA sequencing datastes G. Giurato (University of Salerno, Baronissi, Italy), A. Rinaldi, A. Hashim, M. R. De Filippo, D. Memoli, A. Weisz I4 The MRN complex is a potential target for the treatment of MYCN amplified Neuroblastoma M. Petroni, F. Sardina (Ospedale Bambino Gesù Rome, Italy), C. Heil, V. Veschi, S. Albini, D. Fruci, A. Gulino, G. Giannini P32 Class III β-tubulin is overexpressed in ovarian clear cell and serous carcinoma and represents a novel marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone E. Bignotti (University of Brescia, Italy), C. Romani, P. Todeschini, D.M. Roque, S. Bellone, R.A. Tassi, E. Bandiera, L. Zanotti, N. Buza, E. Cocco, T.J. Rutherford, P.E. Schwartz, A. Ravaggi, E. Sartori, A.D. Santin, S. Pecorelli P31 mirna signature characterization in round cell myxoid liposarcomas treated with trabectedin M. Di Marino (Mario Negri Institute of Milan, Italy), L. Beltrame, L. Paracchini, R. San Filippo, P. Casali, A. Gronchi, S. Pilotti, C. Romualdi, F. Bozzi, T. Negri, E. Calura, S. Marchini, M. D Incalci P36 MicroRNA-10b expression correlates with metastases development and survival in breast cancer patients R. Barbano, B. Pasculli, V.M. Valori, A. Fontana, M. Copetti, M.L. Poeta, G. Perrone, F. Pellegrini, A. Onetti-Muda, R. Murgo, E. Maiello, V.M. Fazio, P. Parrella (IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Foggia, Italy) 14

17 Wednesday 25 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o P26 Evaluation of the prognosis role of IGF1R in prostate cancer patients and association with TMPRSS2-ERG status I. Casanova-Salas (Fundacion Instituto Valenciano de Oncologia, Valencia, Spain), C. Mancarella, J.A. López-Guerrero, K. Scotlandi CANCER STEM CELLS Chairmen A. Morandi (Florence, Italy) - G. Morrone (, Italy) The importance of asymmetry for gene expression in the stem cell compartment of human prostate epithelium N.J. Maitland (York, United Kingdom) Sponsored by EACR Stem cells in homeostasis and cancer the good, the bad and the ugly R. Fodde (Rotterdam, The Netherlands) Clinical implications of cancer stem cell hypothesis L. Ricci-Vitiani (Rome, Italy) Targeting pancreatic cancer stem cells G. Draetta (Houston, USA) Modeling of human leukemias J.J. Schuringa (Groningen, The Netherlands) Depletion of HIPK2 full-length protein preserving the ΔE8 isoform triggers E7 apoptosis in colon cancer stem cells in vitro and in vivo G. Di Rocco, V. Gatti, A. Verdina, M. Pietrafesa, G. Toietta, S. Soddu (National Cancer Institute Regina Elena, Rome, Italy) Radiotherapy induced mir expression influences the formation of local R7 recurrence in breast cancer L. Fabris (CRO National Cancer Institute, Aviano, Italy), S. Berton, S. Massarut, S. D Andrea, G. Calin, B. Belletti, G. Baldassarre AWARD CEREMONY SIC General Assembly Social Dinner 15

18 Thursday 26 September SCIENTIFIC PROGRAMME Ve n u e Vi l l a g g i o Gu g l i e l m o ANIMAL MODELS OF CANCER Chairmen R. Dolcetti (Aviano, PN, Italy) - A. Fusco (Naples, Italy) Mouse models of glioma subtypes E. Holland (New York, USA) The role of hypoxic responses in leukemogenesis R. Bernardi (Milan, Italy) Novel players in tumor microenvironment U. Cavallaro (Milan, Italy) Coffee Break Application of genomics to zebrafish models in cancer research M.A. Rubin (New York, USA) Zebrafish models of cancer M.C. Mione (Eggenstein-Leopoldshafen, Germany) AKT1-E17K is oncogenic in mouse and human lung through p27 delocalization A3 C. De Marco (University of Magna Graecia,, Italy) D. Malanga, O. Paciello, S. Papparella, F. Zito Marino, R. Franco, G. Viglietto Yes-associated protein is required for the clonal expansion of preneoplastic A6 hepatocytes and oval cell proliferation M.A. Kowalik (University of Cagliari, Italy), A. Perra, E. Ghiso, G.M. Ledda-Columbano, S. Giordano, A. Columbano Epigenomics functionally indexing genomes in health and disease H. Stunnenberg (Nijmegen, The Netherlands) CLOSING LECTURE Chair R. Dolcetti (Aviano PN, Italy) From Data to Knowledge Using omics to drive discovery J. Quackenbush (Boston, USA) AWARD FOR THE BEST ORAL SELECTED PRESENTATION CLOSING REMARKS Lunch 16

19 Scientific Information CME Credits No. 2,5 Italian Ministry of Health CME (Continuing Medical Education) credits for the event on September 23 and No 8 CME credits for the event from September 24 to 26 have been assigned for the following categories - Medical Surgeon (Haematology, Medical Genetics, Oncology, Pathological Anatomy, Pharmacology and Clinical Toxicology, Clinical Pathology, Internal Medicine) - Biologist, Pharmacist, Chemist (Analytical Chemistry), Physicist (Health Physics), Veterinary Surgeon AUDIOVISUAL INSTRUCTIONS A Multimedia Slide Centre is located in the Meeting Venue. ONLY PC DATA PROJECTION IS AVAILABLE DURING THE MEETING. Each room is provided with a laptop. Therefore the use of your personal laptop is not allowed. Special requirements should be communicated to the Organizing Secretariat as soon as possible. Power-Point presentations should be handed to the slide centre one hour before the beginning of the session. PRIZES Wednesday September 25 Piero Trivella and EACR Prizes to the best posters Elena Cappannini Prize to the best 2012 publication as first author in innovative approaches for cancer treatments Pezcoller Foundation Scholarship Travel Grants Thursday September 26 Award for the best oral selected presentation 17

20 General Information Dates, 23 26, September 2013 Congress Venue September 23 Università degli Studi Magna Græcia di Viale Europa Germaneto September Villaggio Guglielmo Congress Center Piazza Susanna, Copanello - SIC Secretariat Società Italiana di Cancerologia Via G. Venezian, Milan Ph Fax Web site Organizing Secretariat Adria Congrex Srl Via Sassonia, Rimini RN Ph Fax Web site Language The official language of the Meeting is English. Simultaneous translation will not be provided. Badges Participants are kindly requested to wear their badge throughout the Meeting. Certificates of Attendance Certificate of attendance is issued on request to all registered participants at the end of the Meeting. Exhibition and Sponsorship A technical, pharmaceutical and publication exhibition will take place in the Meeting Venue throughout the scientific works. Additional sponsoring opportunities are available. For any information, please contact the Organizing Secretariat Adria Congrex. 18

55 th. Catanzaro. 23 26 September 2013. Xxxxxxxxxxxxxxxx. : understanding onc-omics for patient-tailored cancer therapy.

55 th. Catanzaro. 23 26 September 2013. Xxxxxxxxxxxxxxxx. : understanding onc-omics for patient-tailored cancer therapy. Xxxxxxxxxxxxxxxx 55 th ABSTRACT SUBMISSION DEADLINE June 7, 2013 1 Committee CONGRESS VENUE Università degli Studi Magna Græcia di Viale Europa - 88100 Germaneto - Villaggio Guglielmo Congress Center Piazza

More information

58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement

58th ANNUAL MEETING OF THE ITALIAN CANCER SOCIETY REVOLUTIONARY ROAD. VERONA SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA. First Announcement SEPTEMBER 5-8 2016 Palazzo della GRAN GUARDIA ABSTRACT DEADLINE May 2, 2016 First Announcement Scientific Coordinators Davide Melisi (Verona) Giampaolo Tortora (Verona) Local Scientific Committee Vincenzo

More information

Dangerous Liaisons. Ferrara, 11-13 September 2014. Università degli Studi di Ferrara. translating cancer biology into better patients management

Dangerous Liaisons. Ferrara, 11-13 September 2014. Università degli Studi di Ferrara. translating cancer biology into better patients management Dangerous Liaisons translating cancer biology into better patients management 56 th Annual Meeting of the Italian Cancer Society Ferrara, 11-13 September 2014 Università degli Studi di Ferrara 1 56 th

More information

Regional Young Investigator SIC meeting. 5-6 March 2015

Regional Young Investigator SIC meeting. 5-6 March 2015 Regional Young Investigator SIC meeting 5-6 March 2015 Aula Magna A - Università Magna Graecia di Catanzaro - Campus Universitario S. Venuta Viale Europa, loc. Germaneto - Catanzaro Invited speakers: Rita

More information

53 rd Annual Meeting of the

53 rd Annual Meeting of the Xxxxxxxxxxxx Back to the Future 53 rd Annual Meeting of the Back to the Future Preliminary Programme 1 53 rd Annual Meeting of the SIC SCIENTIFIC BOARD President Alfredo Fusco ( Federico II University,

More information

Scientific Programme

Scientific Programme Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo Cristiana Sessa Istituto Oncologico

More information

SIC SCIENTIFIC BOARD SCIENTIFIC AND ORGANIZING COMMITTEE

SIC SCIENTIFIC BOARD SCIENTIFIC AND ORGANIZING COMMITTEE 54 th Annual Meeting of the Italian Cancer Society MISSION IMPOSSIBLE: understanding cancer-host dialogues for personalized cancer medicine SIC SCIENTIFIC BOARD President Riccardo Dolcetti (CRO-IRCCS,

More information

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom Luca Gianni Fondazione Centro San Raffaele del Monte Tabor, Milan, Italy Ana Maria Gonzalez-Angulo M.D. Anderson Cancer

More information

Rome, 9-10 June 2016

Rome, 9-10 June 2016 Rome, 9-10 June 2016 1 Exosomes in pathological conditions AICC SCIENTIFIC BOARD President Katia Scotlandi, IRCCS Rizzoli Orthopaedic Institute, Bologna VicePresident Michele Caraglia, Second University

More information

AICC Italian Association of Cell Culture

AICC Italian Association of Cell Culture AICC Italian Association of Cell Culture The AICC was founded in Bologna in 1980 as an Italian wing of the "European Tissue Culture Society" (ETCS) in order to promote the study and application of in vitro

More information

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy Programme Invited Speakers: Reuven Agami (The Netherlands), Manuela Baccarini (Austria), Allan Balmain (USA), Daniel Birnbaum (France), Anne-Lise Børresen-Dale (Norway), Carlos Caldas (UK), Silvana Canevari

More information

INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY 19-20 June 2015

INTERNATIONAL RETREAT OF PhD STUDENTS IN IMMUNOLOGY 19-20 June 2015 LS LS Magna Gr ae cia University of Catanzaro, Italy Preliminary Program PhD PROGRAMME PhD PROGRAMME MOLECULAR AND TRANSLATIONAL ONCOLOGY LIFE SCIENCES ORGANIZING COMMITTEE Professor Ennio Carbone Head

More information

Sezione di Oncologia. [Workshop] LEARNING at the LEANING tower Pisa Colorectal Cancer 2015

Sezione di Oncologia. [Workshop] LEARNING at the LEANING tower Pisa Colorectal Cancer 2015 [Workshop] LEARNING at the LEANING tower Pisa Colorectal Cancer 2015 Pisa, 16-17 Novembre 2015 [ Programma preliminare] Lunedì, 16 novembre 13.30 Registration 13.45 Introduction and welcome Alfredo Falcone,

More information

INTERNATIONAL COURSE:

INTERNATIONAL COURSE: INTERNATIONAL COURSE: Novel mechanisms of signal transduction involved in cancer chemoresistance - Focus on IGF signaling integration and cross-talk. University Campus S Venuta - Catanzaro, Italy Lecture

More information

2011 IRCC International Conference Molecular Clinical Oncology May 26th-28th, 2011, Torino Italy

2011 IRCC International Conference Molecular Clinical Oncology May 26th-28th, 2011, Torino Italy Updated May 23rd, 2011 2011 IRCC International Conference Molecular Clinical Oncology May 26th-28th, 2011, Torino Italy Thursday May 26 th, 2011 (afternoon) Venue: Aula Magna Rettorato 14.00 16.00 Registration

More information

Promises and challenges of developing new drugs in oncology

Promises and challenges of developing new drugs in oncology 3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San

More information

Mediterranean School of Oncology

Mediterranean School of Oncology Mediterranean School of Oncology Organized and supported by: CINBO Consorzio Interuniversitario Nazionale per la Bioncologia HIGHLIGHTS IN THE MANAGEMENT OF COLORECTAL CANCER, February 1-2, 2007 Domus

More information

PROGRAMMA SCIENTIFICO

PROGRAMMA SCIENTIFICO PROGRAMMA SCIENTIFICO MELANOMA BRIDGE 2012, DECEMBER 2 ND -4 TH 2012 Presidents: Paolo A. Ascierto, Francesco M. Marincola and Nicola Mozzillo Scientific Board Paolo A. Ascierto Gennaro Ciliberto Bernard

More information

Scientific Programme

Scientific Programme Scientific Programme Scientific Committee Hilary Calvert UCL Cancer Institute, London, UK Luca Gianni Ospedale San Raffaele IRCCS, Milan, Italy Ana Maria Gonzalez-Angulo The University of Texas, MD Anderson

More information

Promises and challenges of developing new drugs in oncology

Promises and challenges of developing new drugs in oncology 3 rd International Michelangelo Conference Promises and challenges of developing new drugs in oncology Chairman: Luca Gianni, Milan I July 2-3, 2015 Venue: Museo della Scienza e della Tecnologia Via San

More information

Resolving Cancer Heterogeneity:

Resolving Cancer Heterogeneity: INTERNATIONAL SYMPOSIUM ON: Resolving Cancer Heterogeneity: The way to personalised medicine Palazzo della Gran Guardia Verona (Italy), June 30 th July 2 nd, 2016 PROGRAM Organized by: ARC-Net Centre for

More information

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France 11-14 September 2008

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France 11-14 September 2008 33 rd European Symposium on Hormones and Cell Regulation Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers Mont Ste. Odile, Alsace, France 11-14 September 2008 Invited Speakers:

More information

Advances in Biology and Treatment of Malignant Brain Gliomas

Advances in Biology and Treatment of Malignant Brain Gliomas Advances in Biology and Treatment of Malignant Brain Gliomas International Congress 2 nd Edition Rome, June 12-13, 2014 President Giulio Maira Vice Presidents Ruggero De Maria, Antonio Iavarone, Angelo

More information

POST-CONGRESS SATELLITE MEETINGS May 24 th, 2013. Cancer biomarkers 2013

POST-CONGRESS SATELLITE MEETINGS May 24 th, 2013. Cancer biomarkers 2013 20 th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine 45 th Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC) POST-CONGRESS SATELLITE

More information

Stem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS

Stem cells: the diverging goals of regenerative medicine and oncology ROME JULY 1-2, 2010 CALL FOR ABSTRACTS Preliminary Programme INTERNATIONAL CONFERENCE Promoted by: Consiglio Nazionale delle Ricerche In collaboration with Stem cells: the diverging goals of regenerative medicine and oncology CHAIRMEN: KENNETH

More information

International symposium on: The Impact of Genomic Deep Sequencing on

International symposium on: The Impact of Genomic Deep Sequencing on Bologna (Italy), 19 th and 20 th November, 2015 International symposium on: The Impact of Genomic Deep Sequencing on Paediatric Research and Clinical Practice Organized by Paediatrics Unit Sant Orsola

More information

Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)

Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO) Under the Auspices of Organized by 10th International Symposium Advanced Ovarian Cancer: Optimal Therapy. Update Valencia, Spain, 6th March 2015 Directors Andrés Poveda Fundación Instituto Valenciano de

More information

Proposta di studio multicentrico A.I.S.F. Genetica della PBC e PSC

Proposta di studio multicentrico A.I.S.F. Genetica della PBC e PSC Proposta di studio multicentrico A.I.S.F. Genetica della PBC e PSC Coordinatore Pietro Invernizzi A.I.S.F., Rome, 25 February 2011 STUDY 1 Primary biliary cirrhosis Identification of common and uncommon

More information

Future Oncology: Technology, Products, Market and Service Opportunities

Future Oncology: Technology, Products, Market and Service Opportunities Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter

More information

ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN

ORGANIZERS Fundación para la Investigación Médica Aplicada FIMA Clínica Universidad de Navarra CUN D International Symposium: Immunostimulatory monoclonal antibodies and immunomodulation: harvesting the crop Fundación Ramón Areces GENERAL INFORMATION DATES OCTOBER 18th 20th VENUE University of Navarra.

More information

EACR AACR SIC. from Cancer Biology to the Clinic. Advance Programme & Call for Abstracts ITALY 20-23 JUNE. Anticancer Drug Action and Drug Resistance:

EACR AACR SIC. from Cancer Biology to the Clinic. Advance Programme & Call for Abstracts ITALY 20-23 JUNE. Anticancer Drug Action and Drug Resistance: Anticancer Drug Action and Drug Resistance: from Cancer Biology to the Clinic Organised by: Advance Programme & Call for Abstracts -- ORGANIZING COMMITTEE n Richard Marais (UK) - Conference Co-Chair n

More information

CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010

CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 CNIO Frontiers Meetings Molecular Cancer Therapeutics Madrid, March 8 10, 2010 Organisers S. Gail Eckhardt, University of Colorado Denver, Aurora, USA Roy S. Herbst, The University of Texas MD Anderson

More information

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers.

The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Irene Catucci 1,2,12, Paolo Verderio 3,12, Sara Pizzamiglio 3,12, Siranoush Manoukian 4, Bernard Peissel 4, Daniela Zaffaroni

More information

10 th EADO Congress Vilnius, 7-10 May 2014. Ipilimumab update. Michele Maio

10 th EADO Congress Vilnius, 7-10 May 2014. Ipilimumab update. Michele Maio 10 th EADO Congress Vilnius, 7-10 May 2014 Ipilimumab update Michele Maio Medical Oncology and Immunotherapy, Department of Oncology University Hospital of Siena, Istituto Toscano Tumori SIENA, ITALY Evolving

More information

Colorectal cancer xenopatients: A preclinical platform for precision medicine

Colorectal cancer xenopatients: A preclinical platform for precision medicine Colorectal cancer xenopatients: A preclinical platform for precision medicine Livio Trusolino, MD PhD Laboratory of Molecular Pharmacology IRCC, Institute for Cancer Research and Treatment University of

More information

Rilevanza dell innovazione tecnologica per la

Rilevanza dell innovazione tecnologica per la Rilevanza dell innovazione tecnologica per la ricerca traslazionale e la terapia in oncologia Ruggero De Maria Dipartimento di Ematologia Oncologia e Medicina Molecolare, Istituto Superiore di Sanità Translational

More information

Curriculum Vitae. Education. Brief Chronology of Employment. Academic Positions held. Pier Paolo Di Fiore M.D. Ph.D.

Curriculum Vitae. Education. Brief Chronology of Employment. Academic Positions held. Pier Paolo Di Fiore M.D. Ph.D. Pier Paolo Di Fiore M.D. Ph.D. Curriculum Vitae Education 1981 - M.D., summa cum laude, University of Naples, 2nd Medical School, Naples, Italy 1984 - Board in Oncology, summa cum laude, University of

More information

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1 1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY

More information

Curriculum Vitae of Luca Gianni

Curriculum Vitae of Luca Gianni Education: 1976: State University of Milan, Milan, Italy: Medical Doctor with honors 1981: State University of Milan, Milan, Italy: Board- Certified in Internal Medicine Brief Chronology of Activities

More information

National Workshop of Hematology The TP53 Workshop

National Workshop of Hematology The TP53 Workshop National Workshop of Hematology The TP53 Workshop Bologna, 10 th May 2013 Aemilia Hotel Via G. Zaccherini Alvisi, 16 Bologna PROMOTED BY Workshop Presidents Michele Cavo Giovanni Martinelli Pier Luigi

More information

EARLY CANCER DETECTION: ENVIRONMENT, BIOMARKERS AND MECHANISMS

EARLY CANCER DETECTION: ENVIRONMENT, BIOMARKERS AND MECHANISMS Regione Calabria Agenzia Regionale per la Protezione dell Ambiente della Regione Calabria Università Magna Graecia Catanzaro Fondazione Tommaso Campanella Società Italiana di tossicologia Società Europea

More information

VII MEETING OF MOLECULAR ONCOLOGY

VII MEETING OF MOLECULAR ONCOLOGY VII MEETING OF MOLECULAR ONCOLOGY Gruppo di Oncologia Molecolare - SIC POSITANO, MAY 14-17, 2007 Hotel Le Agavi Sponsored by: FIRC - Fondazione Italiana per la Ricerca sul Cancro NOGEC - Naples Oncogenomic

More information

LIQUID BIOPSY: TRACKING CANCER

LIQUID BIOPSY: TRACKING CANCER SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER 29-30 April 2016 first announcement Pierre-Auguste Renoir Chemin montant dans les hautes herbes Organizing Secretariat CONGRESS LINE Via Cremona, 19-00161 Rome

More information

16.30 Kaposi s Sarcoma (KS): an interesting model for studying clinico-pathological relationship in tumorigenesis events

16.30 Kaposi s Sarcoma (KS): an interesting model for studying clinico-pathological relationship in tumorigenesis events VIII th M.O.M.T. MEDITERRANEAN CONGRESS ON ONCOLOGICAL PATHOLOGY GALLIPOLI (LE) October 2015, 9-10 Convention Center - Grand Hotel Costa Brada Gallipoli (LE), ITALY 1 st day, Friday, October 2015, 9 8.30

More information

Data from an interim analysis from the pivotal Phase 3 trial of YONDELIS in soft tissue sarcoma, SAR-3007, will be presented in an oral presentation

Data from an interim analysis from the pivotal Phase 3 trial of YONDELIS in soft tissue sarcoma, SAR-3007, will be presented in an oral presentation PharmaMar announces new advances in oncology at ASCO 2015 for its compounds YONDELIS and PM1183 in small cell lung cancer, soft tissue sarcoma, and mesothelioma Compelling clinical activity of PM1183 in

More information

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Genomic Medicine The Future of Cancer Care Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America Personalized Medicine Personalized health care is a broad term for interventions

More information

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center

Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.

More information

Centro Congressi Hotel Michelangelo ORGANIZING SECRETARIAT. Con il patrocinio di SIE Società Italiana di Ematologia

Centro Congressi Hotel Michelangelo ORGANIZING SECRETARIAT. Con il patrocinio di SIE Società Italiana di Ematologia Con il patrocinio di SIE Società Italiana di Ematologia ORGANIZING SECRETARIAT Studio E.R. Congressi - Triumph Group Via Marconi, 36-40122 Bologna, Italy Phone +39 051 4210559 Fax +39 051 4210174 ercongressi@triumphgroup.it

More information

BREAST CANCER IN YOUNG WOMEN. OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano

BREAST CANCER IN YOUNG WOMEN. OCTOBER 9 th 2015 Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano Centro di Senologia della Svizzera Italiana 8 th Edition BREAST CANCER IN YOUNG WOMEN OCTOBER 9 th Aula Magna UNIVERSITÀ DELLA SVIZZERA ITALIANA Lugano Scientific Coordinators: Olivia Pagani and Alberto

More information

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle TITLE PROJET NOM HOPITAL Assessment of tumor angiogenesis using PET/CT with 18 F-Galacto- RGD. (PNC_29_001) Division of

More information

Nuevas tecnologías basadas en biomarcadores para oncología

Nuevas tecnologías basadas en biomarcadores para oncología Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS

More information

Eventuale spazio per nome struttura o altro. Pharmacy education. The Italian academic viewpoint

Eventuale spazio per nome struttura o altro. Pharmacy education. The Italian academic viewpoint Eventuale spazio per nome struttura o altro Pharmacy education. The Italian academic viewpoint Faculty of Pharmacy Total number of Pharmacy higher education institutes in Italy 1. Faculty of Pharmacy,

More information

CARDIOLOGIA E ARTE MILAN. December 1 st Grand Hotel Barone di Sassj. Sesto San Giovanni PRELIMINARY PROGRAM

CARDIOLOGIA E ARTE MILAN. December 1 st Grand Hotel Barone di Sassj. Sesto San Giovanni PRELIMINARY PROGRAM Sesto San Giovanni PRELIMINARY PROGRAM PRESIDENTS Sesto San Giovanni G. J. Klein University Hospital Card Inv Unit London Ontario Canada A. S. Montenero IRCCS Multimedica Cardiology Dpt. Sesto San Giovanni

More information

TEACH Summer School Cascais, Portugal 3-7 July, 2016. Training and Education for Advanced Clinicians and HCPs in Personalised Medicine

TEACH Summer School Cascais, Portugal 3-7 July, 2016. Training and Education for Advanced Clinicians and HCPs in Personalised Medicine TEACH Summer School Cascais, Portugal 3-7 July, 2016 Training and Education for Advanced Clinicians and HCPs in Personalised Medicine TEACH Summer School Cascais, Portugal 3-7 July, 2016 Objectives There

More information

Monday 27 th October 2014 12,00-14,00 Registration 12,30-14,00 Welcome Buffet

Monday 27 th October 2014 12,00-14,00 Registration 12,30-14,00 Welcome Buffet Scientific Committee Paolo Rossi (President, Rome, Italy); Marco Cappa (Chair, Rome, Italy); Stefano Cianfarani (Rome, Italy); George P. Chrousos (Athens, Greece); Lucia Ghizzoni (Turin, Italy) Sandro

More information

Targeted Therapy What the Surgeon Needs to Know

Targeted Therapy What the Surgeon Needs to Know Targeted Therapy What the Surgeon Needs to Know AATS Focus in Thoracic Surgery 2014 David R. Jones, M.D. Professor & Chief, Thoracic Surgery Memorial Sloan Kettering Cancer Center I have no disclosures

More information

Genomics in Hematology

Genomics in Hematology Università degli Studi di Perugia Genomics in Hematology January 29-31, 2012 Perugia Camera di Commercio Congress Center January 29 th, 2012 Opening Session Teatro del Pavone Chairs: Franco Aversa, Cristina

More information

FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES

FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES FOCUS ON BIOLOGICAL THERAPIES IN HEMATOLOGIC MALIGNANCIES Siena, November 4-5, 2004 AUSPICES SIE SIES University of Siena Department of Medicine and Immunological Sciences Section of Hematology and Transplantion,

More information

ACADEMY MASS SPECTROMETRIC METHODS IN CLINICAL DIAGNOSIS PROGRAM CATANIA 20 JUNE 2008. One Day meeting on: CADEMY

ACADEMY MASS SPECTROMETRIC METHODS IN CLINICAL DIAGNOSIS PROGRAM CATANIA 20 JUNE 2008. One Day meeting on: CADEMY Gruppo Interdivisionale di Chimica del Proteoma Under the auspices of One Day meeting on: MASS SPECTROMETRIC METHODS IN CLINICAL DIAGNOSIS PROGRAM CATANIA 20 JUNE 2008 Auditorium SIFI Via Ercole Patti,

More information

Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases

Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases The International School of Advanced Molecular BioMedicine Complex Systems BioMedicine: Molecules, Signals, Networks, Diseases AciTrezza (Catania), Italy, October 2nd-6th, 2009 Hieronymus Bosch: Garden

More information

SPEAKERS AND CHAIRMEN

SPEAKERS AND CHAIRMEN 44 th COURSE ON ADVANCES IN NEPHROLOGY, DIALYSIS AND TRANSPLANTATION Milan, December 6-9, 2012 Centro Congressi Milan Marriott Hotel Via Washington, 66 - Milan Directors of the Course G. D'AMICO - P. MESSA

More information

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7)

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7) INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (7) Settima scuola estiva di Neuroscienze (7) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL

More information

FARMACI PERSONALIZZATI PER

FARMACI PERSONALIZZATI PER ISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI FONDAZIONE G. Pascale NAPOLI SC Biologia Cellulare e Bioterapie CENTRO RICERCHE ONCOLOGICHE MERCOGLIANO (AV) Laboratorio di Farmacogenomica FARMACI

More information

Overall teaching planning and Istitutional tasks Antonio Cuneo (Hematology), Giovanni Lanza (Pathology)

Overall teaching planning and Istitutional tasks Antonio Cuneo (Hematology), Giovanni Lanza (Pathology) Title of the programme "Normal and abnormal growth of tissues and organs", Discipline - Oncology Period June 2013 Teaching language English Maximum number of students 10 +10 Programme co-ordinators Contactperson

More information

30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens

30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.

More information

DETERMINATION OF HER2 STATUS IN BREAST CANCER PATIENTS BY TWO METHODS: REAL-TIME QUANTITATIVE PCR (QPCR) AND IMMUNOENZIMATIC ASSAY (EIA)

DETERMINATION OF HER2 STATUS IN BREAST CANCER PATIENTS BY TWO METHODS: REAL-TIME QUANTITATIVE PCR (QPCR) AND IMMUNOENZIMATIC ASSAY (EIA) DETERMINATION OF HER2 STATUS IN BREAST CANCER PATIENTS BY TWO METHODS: REAL-TIME QUANTITATIVE PCR (QPCR) AND IMMUNOENZIMATIC ASSAY (EIA) Maria Savino, Paola Parrella, Massimiliano Copetti, Raffaela Barbano,

More information

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved microrna 2 micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved Regulate gene expression by binding complementary regions at 3 regions of target mrnas Act as negative

More information

PRELIMINARY PROGRAMME I ACT. Bologna, 30 th November - 1 st December. Aula Chiantore

PRELIMINARY PROGRAMME I ACT. Bologna, 30 th November - 1 st December. Aula Chiantore PRELIMINARY PROGRAMME I ACT Bologna, 30 th November - 1 st December 2012 Aula Chiantore Institute of Hematology L. e A. Seràgnoli Sant Orsola - Malpighi University Hospital PAV. 8 PROMOTED BY SCIENTIFIC

More information

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7)

INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA. SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7) INTERNATIONAL PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (7) Sesta scuola estiva di Neuroscienze (7) UNDER THE AUSPICES OF THE FEDERATION OF EUROPEAN PHARMACOLOGICAL

More information

MADRID 11/06/09 EPIGENETICS AND NEW THERAPIES IN CANCER. 11-12 June 2009 Madrid, Spain ESO INSIDE TRACK CONFERENCE

MADRID 11/06/09 EPIGENETICS AND NEW THERAPIES IN CANCER. 11-12 June 2009 Madrid, Spain ESO INSIDE TRACK CONFERENCE ESO INSIDE TRACK CONFERENCE MADRID 11/06/09 EPIGENETICS AND NEW THERAPIES IN CANCER 11-12 June 2009 Madrid, Spain Chair: M. Esteller, ES Coordinators: S. Marsoni, IT - M.A. Piris, ES APPLICATION AND ABSTRACT

More information

53 rd Annual Meeting of the

53 rd Annual Meeting of the 53 rd Annual Meeting of the Back to the Future 53 rd Annual Meeting of the SIC SCIENTIFIC BOARD President Alfredo Fusco ( Federico II University, Naples, Italy) President Elect Riccardo Dolcetti (CRO-IRCCS,

More information

National Workshop of Hematology The TP53 Workshop

National Workshop of Hematology The TP53 Workshop PRELIMINARY PROGRAMME National Workshop of Hematology The TP53 Workshop Bologna, 10 th May 2013 Aemilia Hotel Via G. Zaccherini Alvisi, 16 Bologna PROMOTED BY Workshop Presidents Michele Cavo Giovanni

More information

Mediterranean School of Oncology

Mediterranean School of Oncology Mediterranean School of Oncology www.mso.cinbo.org C.M.E. requested HIGHLIGHTS IN THE MANAGEMENT OF BREAST CANCER Rome, June 17, 2011 CINBO Consorzio Interuniversitario Nazionale per la Bio-Oncologia Mediterranean

More information

STRESA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION. 31 March - 1 April 2011 Stresa, Italy. Chairs: P.G. Casali, IT - G. Gatta, IT

STRESA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION. 31 March - 1 April 2011 Stresa, Italy. Chairs: P.G. Casali, IT - G. Gatta, IT ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA 31/03/11 RARE SOLID CANCERS: AN INTRODUCTION 31 March - 1 April 2011 Stresa, Italy Chairs: P.G. Casali, IT - G. Gatta, IT STRESA In collaboration with COURSE

More information

International Workshop TRANSLATIONAL RESEARCH ON MALIGNANT GLIOMAS: FROM DISCOVERY TO CLINIC

International Workshop TRANSLATIONAL RESEARCH ON MALIGNANT GLIOMAS: FROM DISCOVERY TO CLINIC TRANSLATIONAL RESEARCH ON MALIGNANT GLIOMAS: Università degli Studi di Napoli Federico II Consiglio Nazionale delle Ricerche Gruppo Neuro-Oncologico Campano th th Naples, February 18-19, 2010 Villa Doria

More information

Biogenic Amines 2011

Biogenic Amines 2011 Università di Torino Università di Padova Università di Roma Società Italiana di Biochimica e Biologia Molecolare Società Italiana di Biochimica e Biologia Molecolare Gruppo Amine Biogene International

More information

PARKINSON S DISEASE MULTIPLE DOMAINS

PARKINSON S DISEASE MULTIPLE DOMAINS PhD PROGRAM IN NEUROPHARMACOLOGY UNIVERSITY OF CATANIA SUMMER SCHOOL OF NEUROSCIENCE (5) Quinta scuola estiva di Neuroscienze (5) July 7-13, 2007 PARKINSON S DISEASE MULTIPLE DOMAINS Catania Parco degli

More information

Cancer Survivorship Care

Cancer Survivorship Care 1113 Prog FOCUS BERGAMO.qxp 3-09-2013 10:22 Pagina 1 Menarini Foundation Symposia: 000 Focus on Rare Diseases: Cancer Survivorship Care Bergamo (Italy), November 14 th - 16 th, 2013 Organized by CLINICAL

More information

Wednesday, January 24, 2007

Wednesday, January 24, 2007 Wednesday, January 24, 2007 h. 11.00/12.30 Registration and poster positioning (just for Poster Session I) h. 13.00/14.30 Welcome lunch h. 14.30/14.40 Opening remarks Enrico Garattini, Istituto Ricerche

More information

Date and place of birth 28th January 1958; Moretta (Cuneo) (Italy). Two children

Date and place of birth 28th January 1958; Moretta (Cuneo) (Italy). Two children ANNA SAPINO Date and place of birth 28th January 1958; Moretta (Cuneo) (Italy). Two children MEDICAL EDUCATION: Medical Degree, University of Turin (1982); Professional specialization in Pathological Anatomy

More information

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics

Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC

More information

XLI Congresso Associazione Italiana di Cristallografia (AIC) PRELIMINARY PROGRAM

XLI Congresso Associazione Italiana di Cristallografia (AIC) PRELIMINARY PROGRAM XLI Congresso Associazione Italiana di Cristallografia (AIC) PRELIMINARY PROGRAM Verona, 11-14 September 2012 Tuesday September 11 14:00-16:30 Registration 16:30-17:00 Opening Ceremony 17:00-17:50 Prize

More information

Magna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA.

Magna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA. Magna Græcia AORtic Interventional Project (MAORI) 3rd SYMPOSIUM COMPLEX DISEASES OF THORACIC AND THORACO-ABDOMINAL AORTA June 25-26, 2013 University Campus Salvatore Venuta,Catanzaro,Italy Building H,

More information

Consensus conference on salivary gland tumors

Consensus conference on salivary gland tumors Consensus conference on salivary gland tumors Adenoid-cystic carcinoma and high-grade neoplasms A common commitment towards the future October 23rd-24th 2014, School of Medicine, University of Brescia

More information

Interferon Fundamentals 2014

Interferon Fundamentals 2014 From Molecular Mechanisms to Human Diseases Rome, Auditorium Pocchiari Istituto Superiore di Sanità Over the last two decades, we have witnessed a tremendous progress in understanding the mechanisms by

More information

International Symposium on: Pain and Cough

International Symposium on: Pain and Cough International Symposium on: Pain and Cough Florence (Italy), March 19-21, 2015 Organized by DEPARTMENT OF HEALTH SCIENCES DEPARTMENT OF EXPERIMENTAL AND CLINICAL MEDICINE UNIVERSITY OF FLORENCE DEPARTMENT

More information

NAPLES - DECEMBER 5-6, 2011 Hotel San Francesco al Monte

NAPLES - DECEMBER 5-6, 2011 Hotel San Francesco al Monte Melanoma Research: A Bridge from Naples to the World th th NAPLES - DECEMBER 5-6, 2011 Hotel San Francesco al Monte Corso Vittorio Emanuele, 328 www.bridgenaples.com (SOCIETY FOR IMMUNOTHERAPY OF CANCER

More information

CRS workshop 21 st -23 rd November 2013

CRS workshop 21 st -23 rd November 2013 Organizing committee: Prof. Pietro Matricardi Prof. Ida Genta Dr. Rossella Dorati Dr. Barbara Colzani Dr. Giuseppe Tripodo Scientific committee: Prof. Paolo Caliceti Prof. Bice Conti Prof. Elias Fattal

More information

Alp Nano bio International School 4. January 27-31, 2014, Sterzing, Vipiteno (I)

Alp Nano bio International School 4. January 27-31, 2014, Sterzing, Vipiteno (I) Alp Nano bio International School 4 January 27-31, 2014, Sterzing, Vipiteno (I) Program MONDAY 27 January 13:00-14:30 Registration 14:30-14:45 Opening Mariano Anderle, PAT Knowledge Department (Trento)

More information

Achievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for

Achievements Report CURING CANCER. Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for Achievements Report August 2015 CURING CANCER Of all the questions addressed to CPRIT, the toughest is: When are you going to find a cure for cancer? Since cancer is complex and comes in many forms, its

More information

Targeted Therapies in Lung Cancer

Targeted Therapies in Lung Cancer Targeted Therapies in Lung Cancer I Edited by: Simona Carnio Thoracic Oncology Division - St Luigi Hospital Orbassano (TO) - Italy Silvia Novello Department of Oncology - University of Torino - Italy Why

More information

FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H.

FAMILIAL CANCER ESO, CNIO AND NRCO CONFERENCE ON. 19-20 May 2016 Madrid, Spain. Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. INSIDE TRACK CONFERENCE ESO, CNIO AND NRCO CONFERENCE ON FAMILIAL CANCER 19-20 May 2016 Madrid, Spain Chairs: R. Eeles, UK W.D. Foulkes, CA M. Robledo, ES H. Vasen, NL FOREWORD The ESO, CNIO and NRCO Conference

More information

PERSONALIZED CANCER TREATMENT A multidisciplinary event

PERSONALIZED CANCER TREATMENT A multidisciplinary event PERSONALIZED CANCER TREATMENT A multidisciplinary event Free Access to the Scientific Sessions March 20 th - 21 st 2015 La Vague de Saint-Paul Saint-Paul de Vence, France Crédit photo Office de Tourisme

More information

Cambia l algoritmo terapeutico

Cambia l algoritmo terapeutico X Seminario I.T.M.O. Neoplasie a bassa incidenza Istituto di Oncologia Policlinico di Monza Monza 07 Maggio2012? Cambia l algoritmo terapeutico Michele Maio Medical Oncology and Immunotherapy, Department

More information

Curriculum Vitae - Sara Gandini

Curriculum Vitae - Sara Gandini Curriculum Vitae - Sara Gandini Academic information 2004 PHD IN CANCER STUDIES at the University of Birmingham (Public Health), UK. Thesis: Meta-Analysis in Cancer Epidemiology. 1995 MASTER OF SCIENCE

More information

on End Stage Focus on Idiopathic

on End Stage Focus on Idiopathic II International Conference on End Stage Lung DiseaseS: Focus on Idiopathic Pulmonary Fibrosis Padua - Italy, February 22 nd, 2013 Palazzo del Bo - Aula Nievo ENDORSEMENTS WELCOME TO PADUA Italian Association

More information

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Update in Hematology Oncology Targeted Therapies. Mark Holguin Update in Hematology Oncology Targeted Therapies Mark Holguin 25 years ago Why I chose oncology People How to help people with possibly the most difficult thing they may have to deal with Science Turning

More information

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294 AD Award Number: W81XWH-08-1-0030 TITLE: Regulation of Prostate Cancer Bone Metastasis by DKK1 PRINCIPAL INVESTIGATOR: Gregory A. Clines, M.D., Ph.D. CONTRACTING ORGANIZATION: University of Alabama at

More information

Dal germinale al somatico nella identificazione di tumori ereditari

Dal germinale al somatico nella identificazione di tumori ereditari Modena 18-19 novembre 2010 Dal germinale al somatico nella identificazione di tumori ereditari Laura Ottini Tendencies to develop cancer can be inherited Fletcher & Houlston, 2010 Cancer is a genetic disease

More information

New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel

New Frontiers. in Glaucoma. Management. Rome, 7 February 2014 Donna Camilla Savelli Hotel New Frontiers in Glaucoma Management Rome, 7 February 2014 Donna Camilla Savelli Hotel FACULTY Marco Centofanti University of Rome Tor Vergata Head of Glaucoma Research Line IRCCS - Fondazione Bietti Rome

More information